✦ LIBER ✦

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

✍ Scribed by Biessels, G.J.; Kappelle, L.J.

Book ID: 121812803
Publisher: Portland Press
Year: 2005
Tongue: English
Weight: 101 KB
Volume: 33
Category: Article
ISSN: 0300-5127
DOI: 10.1042/BST20051041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Possible involvements of beta-amyloid, i

Possible involvements of beta-amyloid, insulin signaling and tau phosphorylation in the pathological interaction between Alzheimer's disease and diabetes

✍ Sato, Naoyuki; Mori-Ueda, Mari; Tanaka, Toshihisa; Takeda, Shuko; Uchio-Yamada, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Diabetes as a risk factor for Alzheimer'

Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease

✍ Hölscher, Christian 📂 Article 📅 2011 🏛 Portland Press 🌐 English ⚖ 282 KB

O2-04-03 Insulin resistance promotes β a

O2-04-03 Insulin resistance promotes β amyloid peptide generation in the brain of a mouse model of Alzheimer's disease

✍ Jun Wang; Giulio M. Pasinetti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Defective insulin signaling pathway and

Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin

✍ C.G. Jolivalt; C.A. Lee; K.K. Beiswenger; J.L. Smith; M. Orlov; M.A. Torrance; E 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

## Abstract We have evaluated the effect of peripheral insulin deficiency on brain insulin pathway activity in a mouse model of type 1 diabetes, the parallels with Alzheimer's disease (AD), and the effect of treatment with insulin. Nine weeks of insulin‐deficient diabetes significantly impaired the

Serum Lp(α), insulin resistance, metabol

Serum Lp(α), insulin resistance, metabolic risk factors for cardiovascular disease, and the long term effects of bezafibrate in type 2 diabetes

✍ R.S. Elkeles; J.R. Diamond; G. Salerno; C. Hughes; W. Richmond; V. Anyaoku 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Insulin signalling in skeletal muscle of

Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease

✍ M. Meyer; K. Levin; T. Grimmsmann; H. Beck-Nielsen; H. Klein 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 134 KB